Breast Implants Market Size
Study Period | 2019 - 2029 |
Market Size (2024) | USD 2.05 Billion |
Market Size (2029) | USD 2.97 Billion |
CAGR (2024 - 2029) | 7.77 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Breast Implants Market Analysis
The Breast Implant Market size is estimated at USD 2.05 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 7.77% during the forecast period (2024-2029).
The COVID-19 pandemic had a short-term impact on the breast implant market, primarily in the initial lockdown phase and other travel restrictions to curb the spread of infection. Due to this, ongoing and scheduled surgical procedures were delayed or canceled, negatively impacting the market. However, the interest and demand for beauty procedures increased during the pandemic among women in the United States, including implants and augmentation. For instance, according to the April 2021 survey report by the American Society of Plastic Surgeons, 11% of the surveyed women were more inclined toward cosmetic surgery or non-surgical procedures than before the pandemic. Therefore, the market is expected to recover soon from the impact of the pandemic and grow in the future.
The rising prevalence of breast cancer worldwide is one of the significant factors for market growth. According to GLOBOCAN 2020, breast cancer surpassed lung cancer and became the most diagnosed cancer worldwide. According to World Health Organization, in 2020, around 2.3 million women were diagnosed with breast cancer globally. About 7.8 million women have been diagnosed with breast cancer over the last five years. While in Asian women, breast cancer prevalence was so high that it accounted for 22.9% of the total cancer cases in women in 2020. Another factor expected to boost the growth of the market studied is women's increasing inclination and awareness toward breast augmentation and reconstruction procedures for beauty enhancement. For example, per the 2020 International Society for Aesthetic Plastic Surgeons (ISAPS) statistics, there were about 193,073 breast augmentation procedures in the United States in 2020, which was more than any other performed aesthetic surgery.
Additionally, market players in the area are continuously working toward better and more efficient solutions and evolving the life of available products through awareness campaigns regarding breast implants, product launches, collaborations, and mergers and acquisitions, which will complement the market growth. For instance, in June 2020, Allergan Aesthetics, a part of AbbVie Inc., announced the initiation of a digital campaign to improve device tracking and identification and increase its reach to patients having Allergan breast implants called BIO CELL and to inform women about the risks of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Such introduction of advanced breast implants is expected to contribute to the market's growth.
Thus, the factors mentioned earlier are expected to contribute to the growth of the market studied over the forecast period. However, the post-surgery complications and risks associated with the breast implant, along with the high cost, are the major restraining factors for the growth of the breast implant market.
Breast Implants Market Trends
This section covers the major market trends shaping the Breast Implant Market according to our research experts:
Silicone Implant is Expected to Hold Major Share in the Market over Other Types during the Forecast Period
The silicone implant segment is expected to dominate the market over the forecast period owing to rising demand for silicone implants. These implants are silicone shells filled with a plastic gel (silicone) that resemble human fat because of viscosity and are used for breast augmentation or reconstruction. Compared to other types of implants, they feel like natural breast tissue, which is the primary reason they are preferred by most people seeking implants compared to different kinds. Silicone breast implants are approved for breast augmentation in women 22 or older and for breast reconstruction in women of any age by the United States Food and Drug Administration.
New technological advancements and improvements in the existing products of silicone breast implants for breast augmentation and reconstruction are expected to boost the market's growth. For instance, in May 2021, GC Aesthetics Inc., a silicone breast implant manufacturer, announced the launch of a next-generation implant called PERLE, a smooth breast implant with a proprietary surface technology called BioQ. Thus, due to the high demand for silicone-based breast implants, the market is expected to grow during the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
North America holds a significant share of the breast implant market. It is expected to show a similar trend over the forecast period. This is mainly due to the high demand for breast augmentation surgeries due to several regional entertainment industries and self-awareness among women. In North America, the United States is expected to hold the largest market for breast implants in the region during the forecast period.
The demand for cosmetic surgeries and procedures in the United States is very high among women, which is one of the significant factors for market growth. For instance, according to the 2020 American Society of Plastic Surgeons report, breast augmentation was one of the top five cosmetic surgical procedures in 2020 in the United States. Moreover, the total number was 193,073 breast augmentation procedures in 2020. In addition, the increasing prevalence of breast cancer in North America will also complement the market's growth. As per the GLOBOCAN 2020 report, new breast cancer cases in the United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020.
Additionally, the rise in product approvals by various regulatory organizations is expected to contribute to the market's growth. For instance, in January 2022, Mentor Worldwide LLC received the United States Food and Drug Administration for the MENTOR Memory Gel BOOST, a breast implant for breast augmentation in women.
Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period.
Breast Implants Industry Overview
The breast implant market is moderately competitive due to the presence of small and large market players who offer a range of implants for breast augmentation, reconstruction, or other cosmetic procedures and are actively involved in enhancing their offerings in the market. Some market players are AbbVie Inc. (Allergan PLC), Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Johnson & Johnson (Mentor Worldwide LLC), and Polytech Health & Aesthetics GmbH.
Breast Implants Market Leaders
Establishment Labs SA
GC Aesthetics
Laboratories Arion
Groupe Sebbin SAS
AbbVie Inc.
*Disclaimer: Major Players sorted in no particular order
Breast Implants Market News
In October 2022, GC anesthetics received CE approval for the micro-textured anatomical breast implant LUNA xt, which was approved under the new European Medical Device Regulation (MDR).
In June 2022, Coll Plant announced the initiation of a study in large animals for its 3D bio-printed regenerative breast implant program, addressing the demands of breast reconstruction.
Breast Implants Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Breast Cancer
4.2.2 Increasing Number of Breast Augmentation Procedures
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Post Complications and Risks Associated with Breast Implants
4.3.2 High Cost of Breast Implants
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.1 Silicone Implants
5.1.2 Form-stable Implants
5.1.3 Saline Implants
5.1.4 Structured Saline Implants
5.2 By Application
5.2.1 Reconstructive Surgery
5.2.2 Cosmetic Surgery
5.3 By End-user
5.3.1 Hospital
5.3.2 Cosmetology Clinic
5.3.3 Other End-users
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AbbVie Inc. (Allergan PLC)
6.1.2 Establishment Labs SA
6.1.3 GC Aesthetics
6.1.4 Groupe Sebbin SAS
6.1.5 Laboratories Arion
6.1.6 Johnson & Johnson (Mentor Worldwide LLC )
6.1.7 Polytech Health & Aesthetics GmbH
6.1.8 Silimed
6.1.9 Sientra Inc.
6.1.10 Cereplas
6.1.11 HansBioMed
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Breast Implants Industry Segmentation
As per the scope of this report, breast implants are medical devices used to augment the size of breasts, either for cosmetic applications or reconstruction purposes or to correct a congenital abnormality. The procedure involves the usage of breast implants to enhance and improve the size of the breasts. The market is segmented by type (silicone implants, form-stable implants, saline implants, and structured saline implants), application (reconstructive surgery and cosmetic surgery), end-user (hospital, cosmetology clinics, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (USD million) for the above segments.
By Type | |
Silicone Implants | |
Form-stable Implants | |
Saline Implants | |
Structured Saline Implants |
By Application | |
Reconstructive Surgery | |
Cosmetic Surgery |
By End-user | |
Hospital | |
Cosmetology Clinic | |
Other End-users |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Breast Implants Market Research FAQs
How big is the Breast Implant Market?
The Breast Implant Market size is expected to reach USD 2.05 billion in 2024 and grow at a CAGR of 7.77% to reach USD 2.97 billion by 2029.
What is the current Breast Implant Market size?
In 2024, the Breast Implant Market size is expected to reach USD 2.05 billion.
Who are the key players in Breast Implant Market?
Establishment Labs SA, GC Aesthetics, Laboratories Arion, Groupe Sebbin SAS and AbbVie Inc. are the major companies operating in the Breast Implant Market.
Which is the fastest growing region in Breast Implant Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Breast Implant Market?
In 2024, the North America accounts for the largest market share in Breast Implant Market.
What years does this Breast Implant Market cover, and what was the market size in 2023?
In 2023, the Breast Implant Market size was estimated at USD 1.9 billion. The report covers the Breast Implant Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Breast Implant Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Breast Implants Industry Report
Statistics for the 2024 Breast Implants market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Breast Implants analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.